However, the administration of an anti-inflammatory agent, minocycline, reduced tau phosphorylation and other astrocytic inflammatory responses as well as associated neuronal loss, further illustrating the pathogenic contributions of astrocytes to AD (Garwood et al., 2011). This evidence concerns the gene MAPT and Alzheimer disease.